Fios Genomics
Life sciences
Company · Edinburgh
EnteroBiotix
EnteroBiotix is a health drugs firm based in Edinburgh, incorporated in Scotland in 2017 (SC559230), with 1 funding round on the record.
What they do
“EnteroBiotix is a clinical-stage biopharmaceutical company developing best-in-class full-spectrum microbial therapeutics.”
In its own words, on enterobiotix.com
In plain speak
They develop medicines made from microbes to treat disease, and are currently testing these in clinical trials.
In the news
Funding rounds
Grants
Latest from EnteroBiotix
Timeline
- directorMurray, Dr Stewart appointed Director
- from the companyEnteroBiotix Announces First Patient Dosed in Phase 2b RISE Study of EBX-102-02 in Irritable Bowel Syndrome with Constipation
- newsGut health drugs firm EnteroBiotix raises £19m
- from the companyEnteroBiotix’s TrIuMPH Phase 2 trial of EBX-102-02 in IBS selected as a Poster of Distinction at Digestive Disease Week 2026
- newsEnteroBiotix secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome -
- directorMelissa Strange appointed Secretary
- newsEnteroBiotix has completed enrolment in a Phase 2a clinical trial -
- from the companyEnteroBiotix Announces Completion of Enrolment in Phase 2a Trial Evaluating EBX-102-02 Prior to Allogeneic Stem Cell Transplantation
- from the companyEnteroBiotix announces positive Phase 2 TrIuMPH results supporting EBX-102-02 as a potential first-in-class, oral, full-spectrum microbiome therapy for irritable bowel syndrome
- from the companyEnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025
- newsEnteroBiotix announces Results Presentation at Digestive Disease Week 2025
- fundingGrowth, £27m from Thairm Bio, Kineticos Life Sciences, Scottish National Investment Bank
Use this data
Download everything ayeoh holds on EnteroBiotix, free: CSV · JSON-LD. Every row carries its source and date.
Record completeness 70 of 100; not yet held: filed accounts, three years of accounts, turnover, open roles.
On the record
Licensed to sponsor visas (Skilled Worker)
Full accounts filed for the year to 31 December 2025
A director appointed
New shares issued on 30 March 2026 (form SH01, filed 16 April 2026)
A director resigned
A director resigned
Full accounts filed for the year to 31 December 2024
New shares issued on 11 July 2025 (form SH01, filed 28 July 2025)
New shares issued on 28 March 2025 (form SH01, filed 30 April 2025)
A director resigned
Small company accounts filed for the year to 31 December 2023
A director appointed
New shares issued on 26 March 2024 (form SH01, filed 15 April 2024)
A director appointed
New shares issued on 19 January 2024 (form SH01, filed 24 January 2024)
New shares issued on 9 August 2023 (form SH01, filed 15 August 2023)
Small company accounts filed for the year to 31 December 2022
A director appointed
Small company accounts filed for the year to 31 March 2022
A director appointed
Small company accounts filed for the year to 31 March 2021
New shares issued on 25 August 2021 (form SH01, filed 3 September 2021)
Small company accounts filed for the year to 31 March 2020
Incorporated at Companies House
Listed by Scottish EDGE: it is a Scottish EDGE alumnus (a winner of its funding and support competition)
More life sciences companies in Edinburgh
Invizius
Life sciences
Kāhu SiliconBio
Life sciences
Lario Therapeutics
Life sciences
MedAscend
Life sciences
OGI Bio
Life sciences
Regenerus Laboratories
Life sciences
Bioliberty
Life sciences
Related
Scottish tech in one email,
every Monday.
Today's Scottish tech news on the front page
Every line on this page comes from the record and links to where it was published or filed.
Something to add or correct? Write to ayeoh@loopsio.com and we'll update it.
Is this your company? Claim this page with your work email to send corrections.
Featured on ayeoh? Get the badge for your site.